Kyverna Therapeutics (KYTX) EPS (Basic) (2023 - 2026)
Kyverna Therapeutics (KYTX) posted EPS (Basic) of -$1.23 for Q1 2026, down 32.89% on a QoQ basis from -$0.92 in Q4 2025, and down 16.44% year-over-year from -$1.47 in Q1 2025.
Kyverna Therapeutics (KYTX) EPS (Basic) (2023 - 2026) Analysis & Trends
Kyverna Therapeutics' EPS (Basic) history runs 4 years deep, the most recent figure standing at -$1.23 for Q1 2026.
- Quarterly EPS (Basic) fell 16.44% year-over-year to -$1.23 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.51 (up 11.11% YoY) and the FY2025 annual result came in at -$4.62, down 35.95% from the prior year.
- EPS (Basic) was -$1.23 for Q1 2026 at Kyverna Therapeutics, down from -$0.92 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.92 in Q4 2025 and bottomed at -$28.21 in Q4 2023.
- A 4-year average of -$7.41 and a median of -$1.2 in 2024 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2024 — EPS (Basic) jumped 96.26% — and 2025, when it declined 21.37%.
- Kyverna Therapeutics' EPS (Basic) stood at -$28.21 in 2023, then soared by 96.26% to -$1.05 in 2024, then climbed by 12.43% to -$0.92 in 2025, then plunged by 32.89% to -$1.23 in 2026.
- Business Quant data shows KYTX's EPS (Basic) at -$1.23 in Q1 2026, -$0.92 in Q4 2025, and -$1.22 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Kyverna Therapeutics | 447.52 Mn | 447.52 Mn | - | -1.23 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.23 |
| Dec 31, 2025 | -0.92 |
| Sep 30, 2025 | -1.22 |
| Jun 30, 2025 | -1.02 |
| Mar 31, 2025 | -1.05 |
| Dec 31, 2024 | -1.05 |
| Sep 30, 2024 | -1.00 |
| Jun 30, 2024 | -0.96 |
| Mar 31, 2024 | -1.20 |
| Dec 31, 2023 | -28.21 |
| Sep 30, 2023 | -24.08 |
| Jun 30, 2023 | -21.73 |
| Mar 31, 2023 | -12.66 |